CellsBin Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$7.3M
- Investors
-
7
CellsBin General Information
Description
Developer of a rare-cell analysis platform designed to support precision medicine, diagnostics, and cell therapy monitoring. The company offers rare-cell detection, single-cell profiling, molecular diagnostics, AI-driven biological intelligence, therapeutic cell monitoring, and precision medicine platforms, enabling researchers, clinicians, and biopharmaceutical companies to detect, quantify, and analyze rare cells for disease monitoring, treatment response assessment, and clinical decision-making.
Contact Information
Website
www.cellsbin.comCorporate Office
- 101 College Street
- Branford, CT 06510
- United States
Corporate Office
- 101 College Street
- Branford, CT 06510
- United States
CellsBin Timeline
CellsBin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 22-Sep-2026 | $7.3M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 16-Oct-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 24-Oct-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | 10-May-2023 | Completed | Startup |
CellsBin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Series A | 82,731,000 | $0.000010 | 8% | $0.07 | $0.07 | 1x | $0.07 | 32.55% |
CellsBin Patents
CellsBin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025155756-A1 | Devices for biological analysis | Inactive | 17-Jan-2024 | ||
| US-12188866-B2 | Devices for biological analysis | Active | 18-Jul-2022 | ||
| US-20240210317-A1 | Devices for biological analysis | Active | 18-Jul-2022 | ||
| US-20250237602-A1 | Devices for biological analysis | Pending | 18-Jul-2022 | ||
| WO-2024019988-A1 | Devices for biological analysis | Inactive | 18-Jul-2022 | G01N21/4788 |
CellsBin Signals
CellsBin Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 108 BioCapital | Other Private Equity | Minority | ||
| Connecticut Innovations | Venture Capital | Minority | ||
| Hatcher+ | Venture Capital | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority | ||
| Endless Frontier Labs | Accelerator/Incubator | Minority |
CellsBin FAQs
-
When was CellsBin founded?
CellsBin was founded in 2022.
-
Where is CellsBin headquartered?
CellsBin is headquartered in Branford, CT.
-
What is the size of CellsBin?
CellsBin has 10 total employees.
-
What industry is CellsBin in?
CellsBin’s primary industry is Discovery Tools (Healthcare).
-
Is CellsBin a private or public company?
CellsBin is a Private company.
-
What is the current valuation of CellsBin?
The current valuation of CellsBin is .
-
What is CellsBin’s current revenue?
The current revenue for CellsBin is .
-
How much funding has CellsBin raised over time?
CellsBin has raised $7.3M.
-
Who are CellsBin’s investors?
108 BioCapital, Connecticut Innovations, Hatcher+, Plug and Play, and Endless Frontier Labs are 5 of 7 investors who have invested in CellsBin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process